Back To Press Release

Novartis renews commitment to malaria elimination, investing USD 100 million to research and develop next-generation antimalarials

Imagining a malaria-free world

Imagining a malaria-free world (Source: Novartis International AG | 6 years ago)

 Video
Getting the job of malaria done

Getting the job of malaria done (Source: Novartis International AG | 6 years ago)

 Video
Striving to eliminate malaria

Striving to eliminate malaria (Source: Novartis International AG | 6 years ago)

 Video
Malaria in African children

Malaria in African children (Source: Novartis International AG | 6 years ago)

 Video
Fighting malaria in the lab

Fighting malaria in the lab (Source: Novartis International AG | 6 years ago)

 Video
Agnes Akoth– A life dedicated to fighting malaria

Agnes Akoth– A life dedicated to fighting malaria (Source: Novartis International AG | 6 years ago)

 Video
Link

Novartis (Source: Novartis International AG | 6 years ago)

Link
Link

To download a copy of the MalaFA report (Source: Novartis International AG | 6 years ago)

Link
Link

iCCM Key Strategy (Source: Novartis International AG | 6 years ago)

Link
Link

For more information on our work in malaria (Source: Novartis International AG | 6 years ago)

Link
Link

Malaria Summit of the Commonwealth Heads of Government (Source: Novartis International AG | 6 years ago)

Link
Link

Vas Narasimhan, CEO of Novartis, LinkedIn (Source: Novartis International AG | 6 years ago)

Link
Link

Story - Meet Martin Grobusch, malaria fighter (Source: Novartis International AG | 6 years ago)

Link
Link

Story - Malaria is still disrupting lives, despite progress (Source: Novartis International AG | 6 years ago)

Link
Link

Story - Researchers overcome hurdles to test experimental malaria drug (Source: Novartis International AG | 6 years ago)

Link